Navigation Links
Accuray Announces First CyberKnife System in South America
Date:8/2/2012

SUNNYVALE, Calif., Aug. 2, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that doctors at Instituto Neurologico de Colombia (INDEC) in Medellin, Colombia are now treating patients using the first and only robotic radiosurgery system designed to treat cancerous and non-cancerous tumors anywhere in the body, including the head, spine, lung, prostate, liver and pancreas. INDEC is the first center in South America to offer the CyberKnife® Robotic Radiosurgery System, which today is used as an alternative to both conventional radiation therapy and surgery at leading centers around the world.

INDEC began treating patients with their CyberKnife System in May 2012 and to date they have treated patients with intracranial, prostate, spine, lung and liver tumors.  Patients treated at INDEC represent the first in South America to receive radiosurgical treatment for both intracranial and extracranial tumors. The first patient was a patient from Bolivia who was treated for a tumor in his spine that was untreatable with the available technologies in his country.

"We take pride in offering a team of highly specialized physicians that work with the most advanced cancer treatment options available," said David Gomez, radiotherapist and director of the Cyberknife unit at INDEC. "The Cyberknife System represents the next step in innovative cancer treatment by allowing our physicians to offer the most personalized care delivered with unparalleled accuracy, ensuring that each patient receives the best treatment available." 

"According to the global business intelligence firm GlobalData, the worldwide radiation therapy market is expected to reach more than $3.6 billion by 2018. A critical part of
'/>"/>

SOURCE Accuray Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Accuray Surpasses 600 Installations Globally
2. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
3. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
4. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
5. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
6. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
7. WuXi PharmaTech Announces Third-Quarter 2011 Results
8. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
9. Spherix Announces Third Quarter Financial Results
10. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
11. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... N.M., Dec. 12 Biomoda, Inc. (OTC,Bulletin Board: ... New,Mexico Institute of Mining and Technology (New Mexico ... to collaborate on clinical,studies and the development of ... commercialization of its assay for the early,detection of ...
... mg/Day Dose for PRISTIQ for the ... Treatment of Major Depressive Disorder, COLLEGEVILLE, Pa., ... WYE ), announces that data from,two Phase 3 clinical studies ... patients who received a 50 mg/day dose of PRISTIQ for ...
... expanding pipeline of products to ... treat ophthalmic diseases, ... developing novel therapeutics for the treatment,of ophthalmic diseases announced today ... a strong, international syndicate of new and,existing investors led by ...
Cached Biology Technology:Biomoda Announces Collaborative Agreement With New Mexico Tech 2New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 2New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 3New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 4New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 5New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo 6Fovea Pharmaceuticals Completes EUR30M Series B Financing 2Fovea Pharmaceuticals Completes EUR30M Series B Financing 3Fovea Pharmaceuticals Completes EUR30M Series B Financing 4
(Date:4/15/2014)... global experts who study the deadliest infectious diseases recognized ... Ksiazek, professors at the University of Texas Medical Branch, ... International Symposium on Filoviruses. The filoviruses include Ebola and ... percent of people infected. The current outbreak of Ebola ... 100 deaths so far. , "This award represents ...
(Date:4/15/2014)... Zealand,s pastoral landscapes are some of the loveliest in ... Many of the country,s pasture soils have become enriched ... which is then eaten by the cattle and sheep ... New Zealand; cadmium-enriched soils being reported worldwide. , The ... levels in meat and dairy products, human health and ...
(Date:4/15/2014)... Sciences (KNAW) has announced the names of five internationally ... (one million US dollars prize money in total). The ... to science. , This year marks the 50th anniversary ... chemist Erwin Chargaff in 1964. , KNAW juries ... laureates: , Christopher M. Dobson, John Humphrey ...
Breaking Biology News(10 mins):International research group recognizes UTMB experts 2International research group recognizes UTMB experts 3Five scientists awarded prestigious Heineken Prizes 2
... and Molecular Biology of Universitat Autnoma de Barcelona ... with a tendency to cause conformational diseases such ... amyloidotic cardiomyopathy, etc. finally end up causing them. ... 3D structure and studied why these proteins finally ...
... protein found present in all cells in the body could ... at the University of Edinburgh have found that the protein ... in lipid droplets the parts of cells used to ... of invadolysin were linked to reduced amounts of fat deposits. ...
... was a frightening failure in drug safety processes. In ... died after being administered contaminated doses of the common ... in China and discovered with the help of scientists ... pure heparin that is was undetectable to all but ...
Cached Biology News:Mechanism related to the onset of various genetic diseases revealed 2Mechanism related to the onset of various genetic diseases revealed 3Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals 2Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals 3
Large-capacity refrigerated incubator chamber holds up to 4 independently-operated shakers. Programmable heat, refrigeration, humidifcation are standard. Photosynthetic operation, optional....
...
... and disposable ESI Chip allow users to ... electrospray mass spectrometers for life science applications. ... to either speed analysis for increased throughput ... or long acquisition times for proteomics and ...
... are optimised for SYBR Green I assays and ... PCR, with the exception of template and primers. ... levels of active SYBR Green I dye and ... buffer that enables detection of low copy number ...
Biology Products: